GLP-1 and alcohol
People kept reporting they wanted a drink less. A randomised trial went and tested it. Here is what it found, and the separate practical question of drinking on a slowed stomach.
Key takeaways
- Many people report wanting alcohol less on a GLP-1. That effect is now supported by a randomised trial, not just anecdote.
- In a phase 2 randomised trial of 48 adults with alcohol use disorder, low-dose semaglutide reduced alcohol craving and how much people drank over nine weeks.
- It is early evidence: small, short, phase 2, and in a specific population. No GLP-1 is approved to treat alcohol use disorder.
- The practical caution is separate from the research: alcohol on a slowed stomach hits differently, and it stacks with dehydration when nausea is already in play.
- Alcohol is also a common reason a weight plateau appears without any obvious change in eating.
Why people want it less
The most consistent thing people report about GLP-1 medication and alcohol is not that drinking became unpleasant. It is that the wanting quietened.
That maps onto the same description people use about food. "Food noise" going quiet and "I just stopped reaching for a drink" are the same kind of observation, which is why the reward-pathway explanation has been taken seriously enough to test properly.
What the trial actually found
A randomised, double-blind, placebo-controlled phase 2 trial tested low-dose semaglutide in adults with alcohol use disorder. 48 non-treatment-seeking participants, nine weeks of outpatient treatment, published in JAMA Psychiatry in 2025.
| Outcome | Result versus placebo |
|---|---|
| Alcohol consumed in a laboratory self-administration test | Reduced |
| Weekly alcohol craving | Significantly reduced |
| Weekly consumption measures | Reduced on some measures, not all |
| Cigarettes per day, in participants who smoked | Greater relative reduction |
Read the size before the direction. Forty-eight people over nine weeks is a signal worth following, not a settled result. The authors framed it as justifying larger trials, which is the correct reading. No GLP-1 is approved for alcohol use disorder, and nobody should start one for that reason on the strength of this.
Is it safe to drink on a GLP-1?
There is no direct interaction between alcohol and semaglutide or tirzepatide in the way there is with, say, metronidazole. The cautions are mechanical.
- It can hit harder and later. Slowed gastric emptying changes how fast alcohol reaches your bloodstream. The dose you are used to may not behave the way you are used to.
- Dehydration stacks. Alcohol is a diuretic; so is a week of nausea and reduced fluid intake. Dehydration is the mechanism behind a large share of GLP-1 emergency presentations.
- It aggravates the gut symptoms you already have. Reflux, nausea and a stomach that already feels full do not improve with drinking.
- Hypoglycaemia risk, if you also take insulin or a sulfonylurea. Alcohol interferes with the liver's glucose release. This combination is worth an explicit conversation.
None of that is a prohibition. It is the reason "a couple of drinks" is a different proposition than it was before you started.
Alcohol and the plateau
Alcohol is one of the most common explanations for a plateau that appears without any obvious change in eating. It carries calories that most people do not count, it disinhibits food choices afterwards, and it disrupts sleep, which affects appetite regulation the following day.
If your weight has stalled and nothing about your meals has changed, this is worth looking at before concluding the medication has stopped working. Our plateau guide covers the full list of things to check first.
Common questions
- Can you drink alcohol on Ozempic or Wegovy?
- There is no direct drug interaction, but the practical cautions are real: alcohol can affect you differently on a slowed stomach, it compounds dehydration when nausea is already present, and it raises hypoglycaemia risk if you also take insulin or a sulfonylurea. Ask your prescriber about your own situation.
- Do GLP-1 medications reduce alcohol cravings?
- A randomised phase 2 trial of 48 adults with alcohol use disorder found low-dose semaglutide significantly reduced weekly alcohol craving and reduced drinking on several measures over nine weeks. It is early evidence and no GLP-1 is approved to treat alcohol use disorder.
- Does alcohol stop GLP-1 weight loss?
- It does not block the drug, but it is one of the most common causes of a plateau appearing without any change in eating — uncounted calories, disinhibited food choices afterwards, and disrupted sleep.
- Why does one drink feel like more now?
- Slowed gastric emptying changes the rate at which alcohol reaches the bloodstream, and reduced food intake means there is often less in the stomach to slow absorption.
Sources
Every figure on this page traces to one of these. Regulatory documents and peer-reviewed primary research only — see our editorial policy for what we accept as a source.
- Hendershot CS et al. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry, 2025. View source
- WEGOVY (semaglutide) injection, US prescribing information. FDA, 2025. View source
- Sodhi M et al. Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. JAMA, 2023. View source
- GLP-1 Agonists: What They Are, How They Work & Side Effects. Cleveland Clinic. View source
Spot what actually changed
When the scale stalls, the useful question is what moved. GLPme keeps food noise, protein and weight trend together so you can see it. Core tracking is free.
